ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

Univ. Of Pittsburg distances Itself From Fisher

June 24, 1994

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

NCI Advised To Seek Greater Local Contribution to Construction Projects; Other changes Asked

January 28, 1977